Influenza A virus (H1N1) 拉丁名
ATCC
VR-1894
編號
Classification Orthomyxoviridae, Influenzavirus A
Agent Influenza A virus (H1N1)
Strain A/California/07/2009 (H1N1)pdm09
Biosafety Level 安全等級 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式 frozen 0.5 mL per vial
Clarified allantoic fluid from inoculated eggs
Storage Conditions -70°C or colderComments
The US Food and Drug Administration recommended A/California/07/2009 (H1N1)pdm09 virus for use as a vaccine during the 2009-2010 influenza season.
The US Food and Drug Administration recommended A/California/07/2009 (H1N1)pdm09-like viruses for use as vaccines during the 2010-2011 influenza season.
The World Health Organization recommended influenza A/California/07/2009 (H1N1)pdm09-like viruses for use as vaccines during the 2010 Southern Hemisphere and the 2010-2011 Northern Hemisphere influenza seasons.
Effect on Host
Hemagglutinates turkey RBCRecommended Host
SPF chicken embryonated eggs, 9-11 days old
Growth Conditions 生長條件
Temperature 培養(yǎng)溫度 : 35°C
Recommendations for Infection: Inoculate SPF chicken embryonated eggs (intra-allantoic) at 9-11 days old. Dilute virus in D-PBS prior to inoculation.
Incubation: 2 days at 35°C in a humidified, non-CO2 atmosphere.
Effect on Host
Hemagglutinates turkey RBC
Name of Depositor 寄存人 D Wentworth, CDC
Chain of Custody 來源國家 ATCC <-- CDC
Source Isolated from a human in California, USA on April 9, 2009.
References 參考文獻
Influenza Research Database – Details for A/California/7/2009(H1N1)
National Center for Immunization and Respiratory Diseases, CDC. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 58(RR-10): 1-8, 2009. PubMed: 19713882
Fiore AE, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 59(RR-8): 1-62, 2010. PubMed: 20689501
WHO recommendations on the composition of influenza virus vaccines